Condition | Indicated | Relationship Strength | Studies | Trials |
Diathesis [description not available] | 0 | 2.25 | 1 | 0 |
Blood Poisoning [description not available] | 0 | 2.25 | 1 | 0 |
Acute Kidney Failure [description not available] | 0 | 2.25 | 1 | 0 |
Bleeding [description not available] | 0 | 2.25 | 1 | 0 |
Hemorrhage Bleeding or escape of blood from a vessel. | 0 | 2.25 | 1 | 0 |
Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. | 0 | 2.25 | 1 | 0 |
Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. | 0 | 2.25 | 1 | 0 |
Abdominal Aortic Aneurysm [description not available] | 0 | 2.31 | 1 | 0 |
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.88 | 3 | 0 |
Aortic Aneurysm, Abdominal An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm. | 0 | 2.31 | 1 | 0 |
Atherogenesis [description not available] | 0 | 2.17 | 1 | 0 |
Atheroma [description not available] | 0 | 2.17 | 1 | 0 |
Aortic Diseases Pathological processes involving any part of the AORTA. | 0 | 2.17 | 1 | 0 |
Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. | 0 | 2.17 | 1 | 0 |
Cardiac Hypertrophy Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. | 0 | 2.08 | 1 | 0 |
Cardio-Cutaneous Syndrome [description not available] | 0 | 2.08 | 1 | 0 |
Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. | 0 | 2.08 | 1 | 0 |
Breast Cancer [description not available] | 0 | 2.1 | 1 | 0 |
Experimental Mammary Neoplasms [description not available] | 0 | 2.1 | 1 | 0 |
Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 2.1 | 1 | 0 |
Asthma, Bronchial [description not available] | 0 | 2.13 | 1 | 0 |
Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). | 0 | 2.13 | 1 | 0 |
Leucocythaemia [description not available] | 0 | 2.04 | 1 | 0 |
Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) | 0 | 2.04 | 1 | 0 |